Learn how digital technology and transformation can optimize outcomes, show the value of therapies, and build consumer trust through the value chain, from R&D to point of care. Join us June 12, 2018 for, "Digital Transformation in the Life Sciences," sponsored by IBM Watson Health.
The event will take place at IBM Watson HQ starting at 6:00 p.m., featuring a keynote address by Dr. Francoise Simon of Columbia University, Mount Sinai School of Medicine, and author of, Managing Biotechnology: from Science to Market in the Digital Age. A panel discussion and networking reception will follow.
Keynote Synopsis: This presentation will focus on digital transformation through the value chain, from R&D to point of care. Research is now greatly facilitated by data analytics tools, led by IBM Watson Health, and clinical trials are optimized by alliances with online patient groups and remote monitoring. Communications are guided by a new understanding of the entire patient journey, from pre-diagnosis to post-treatment. This new model entails the parallel development of therapies, diagnostics, and biomarkers. It relies on patient engagement and co-creation from early discovery to the market. While challenges remain, digital technologies hold great promise to optimize outcomes, show the value of therapies and build consumer trust.
Dr. Francoise Simon is Professor Emerita at Columbia University and Senior Faculty, Mount Sinai School of Medicine. Her teaching focuses on graduate and executive programs and won the Chandler Award for Commitment to Excellence from the Columbia Business School. She has published over twenty articles and conducted more than 200 management seminars in the Americas, Europe, and Asia. She is the co-author of Managing Biotechnology: From Science to Market in the Digital Age, with Glen Giovannetti (Wiley, 2017).
Amy West, Sr. Director Patient Centric Marketing & Digital Health Innovation. Novo Nordisk Leader of US patient centric marketing & digital health innovation strategy and execution including establishing and advancing the US patient marketing and digital health strategic roadmap, business development, innovative multichannel marketing initiatives and commercial execution for the diabetes portfolio.
Lisa Rometty, General Manager Life Sciences, Oncology & Genomics at IBM Watson Health Recently named General Manager of IBM Watson Health’s Life Science, Oncology and Genomics organization, Lisa brings over 25 years of strong commercial leadership experience in global marketing, public relations, business development, strategic partnerships, and client engagement to the role.
Aviva deBeer (Moderator), Global Solution Executive at IBM Watson Health
* - Walk-ins will be accepted at the door until event capacity is reached.
6:00 p.m. - 6:30 p.m. Arrival
6:30 p.m. - 7:00 p.m. Introduction and Keynote "New Digital Dynamics in Healthcare"
7:00 p.m. - 7:30 p.m. Panel
7:30 p.m. - 8:30 p.m. Networking